Historical Valuation
Creative Medical Technology Holdings Inc (CELZ) is now in the Fair zone, suggesting that its current forward PS ratio of 8605.62 is considered Fairly compared with the five-year average of -1.31. The fair price of Creative Medical Technology Holdings Inc (CELZ) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：2.25
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Creative Medical Technology Holdings Inc (CELZ) has a current Price-to-Book (P/B) ratio of 0.91. Compared to its 3-year average P/B ratio of 0.71 , the current P/B ratio is approximately 27.31% higher. Relative to its 5-year average P/B ratio of -3.35, the current P/B ratio is about -127.12% higher. Creative Medical Technology Holdings Inc (CELZ) has a Forward Free Cash Flow (FCF) yield of approximately -85.24%. Compared to its 3-year average FCF yield of -106.50%, the current FCF yield is approximately -19.96% lower. Relative to its 5-year average FCF yield of -75.06% , the current FCF yield is about 13.57% lower.
P/B
Median3y
0.71
Median5y
-3.35
FCF Yield
Median3y
-106.50
Median5y
-75.06
Competitors Valuation Multiple
AI Analysis for CELZ
The average P/S ratio for CELZ competitors is 1436.13, providing a benchmark for relative valuation. Creative Medical Technology Holdings Inc Corp (CELZ.O) exhibits a P/S ratio of 8605.62, which is 499.22% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for CELZ
1Y
3Y
5Y
Market capitalization of CELZ increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of CELZ in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is CELZ currently overvalued or undervalued?
Creative Medical Technology Holdings Inc (CELZ) is now in the Fair zone, suggesting that its current forward PS ratio of 8605.62 is considered Fairly compared with the five-year average of -1.31. The fair price of Creative Medical Technology Holdings Inc (CELZ) is between to according to relative valuation methord.
What is Creative Medical Technology Holdings Inc (CELZ) fair value?
CELZ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Creative Medical Technology Holdings Inc (CELZ) is between to according to relative valuation methord.
How does CELZ's valuation metrics compare to the industry average?
The average P/S ratio for CELZ's competitors is 1436.13, providing a benchmark for relative valuation. Creative Medical Technology Holdings Inc Corp (CELZ) exhibits a P/S ratio of 8605.62, which is 499.22% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Creative Medical Technology Holdings Inc (CELZ) as of Jan 10 2026?
As of Jan 10 2026, Creative Medical Technology Holdings Inc (CELZ) has a P/B ratio of 0.91. This indicates that the market values CELZ at 0.91 times its book value.
What is the current FCF Yield for Creative Medical Technology Holdings Inc (CELZ) as of Jan 10 2026?
As of Jan 10 2026, Creative Medical Technology Holdings Inc (CELZ) has a FCF Yield of -85.24%. This means that for every dollar of Creative Medical Technology Holdings Inc’s market capitalization, the company generates -85.24 cents in free cash flow.
What is the current Forward P/E ratio for Creative Medical Technology Holdings Inc (CELZ) as of Jan 10 2026?
As of Jan 10 2026, Creative Medical Technology Holdings Inc (CELZ) has a Forward P/E ratio of -1.26. This means the market is willing to pay $-1.26 for every dollar of Creative Medical Technology Holdings Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Creative Medical Technology Holdings Inc (CELZ) as of Jan 10 2026?
As of Jan 10 2026, Creative Medical Technology Holdings Inc (CELZ) has a Forward P/S ratio of 8605.62. This means the market is valuing CELZ at $8605.62 for every dollar of expected revenue over the next 12 months.